🇺🇸 FDA
Patent

US 11219636

Compositions and methods for treating cancer

granted A61KA61K2300/00A61K31/713

Quick answer

US patent 11219636 (Compositions and methods for treating cancer) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
Grant date
Tue Jan 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2300/00, A61K31/713, A61K35/761, A61K45/06